These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 8254047

  • 1. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
    März W, Baumstark MW, Scharnagl H, Ruzicka V, Buxbaum S, Herwig J, Pohl T, Russ A, Schaaf L, Berg A.
    J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.
    Hoeg JM, Demosky SJ, Schaefer EJ, Starzl TE, Brewer HB.
    J Clin Invest; 1984 Feb; 73(2):429-36. PubMed ID: 6321555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D, Schuster H, Zöllner N.
    Eur J Med Res; 1996 May 24; 1(8):383-6. PubMed ID: 9360938
    [Abstract] [Full Text] [Related]

  • 6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov 24; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 7. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
    Durovic S, März W, Frank S, Scharnagl H, Baumstark MW, Zechner R, Kostner GM.
    J Biol Chem; 1994 Dec 02; 269(48):30320-5. PubMed ID: 7982944
    [Abstract] [Full Text] [Related]

  • 8. Family study in familial hypercholesterolemia with a receptor-negative homozygous 9-year-old boy.
    Clemens P, Beisiegel U, Steinhagen-Thiessen E.
    Helv Paediatr Acta; 1986 Aug 02; 41(3):173-82. PubMed ID: 2944857
    [Abstract] [Full Text] [Related]

  • 9. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M, Hapizah MN, Khalid BA, Khalid Y, Rosli A, Jamal R.
    Malays J Pathol; 2006 Jun 02; 28(1):7-15. PubMed ID: 17694954
    [Abstract] [Full Text] [Related]

  • 10. [Pravastatin increases the activity pf the LDL receptors in lymphocytes of individuals with heterozygous familial hypercholesterolemia].
    Alvarez-Sala LA, Mata P, Blázquez E, Garrido JA, Ordovás JM, Rubio MJ, de Oya M.
    Rev Clin Esp; 1997 May 02; 197(5):317-22. PubMed ID: 9280964
    [Abstract] [Full Text] [Related]

  • 11. A flow cytometric competition technique for measuring interaction of LDL with cellular LDL-receptors applied to patients with mutant (Arg3500-->Gln) apolipoprotein B.
    Heath F, Jensen TG, Hansen PS, Jensen LG, Vissinger H, Moestrup SK, Pedersen S, Kølvraa S, Bolund L, Faergeman O.
    Z Gastroenterol; 1996 Jun 02; 34 Suppl 3():21-4. PubMed ID: 8767450
    [Abstract] [Full Text] [Related]

  • 12. Familial defective apolipoprotein B-100 (FDB): effect of simvastatin therapy on LDL-receptor binding.
    Mamotte CD, Sturm M, Foo JI, van Bockxmeer FM, Taylor RR.
    Atherosclerosis; 1996 Aug 23; 125(1):103-10. PubMed ID: 8831932
    [Abstract] [Full Text] [Related]

  • 13. Conformationally specific enhancement of receptor-mediated LDL binding and internalization by peptide models of a conserved anionic N-terminal domain of human apolipoprotein E.
    Braddock DT, Mercurius KO, Subramanian RM, Dominguez SR, Davies PF, Meredith SC.
    Biochemistry; 1996 Nov 05; 35(44):13975-84. PubMed ID: 8909295
    [Abstract] [Full Text] [Related]

  • 14. Interaction of normolipidemic very low density lipoproteins with receptors in human skin fibroblasts.
    Yamamoto M, Ranganathan S, Kottke BA.
    Biochem Int; 1985 Oct 05; 11(4):573-81. PubMed ID: 3853463
    [Abstract] [Full Text] [Related]

  • 15. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G, Dobmeyer J, Nissen H, Hansen TS.
    Am J Med Genet; 1996 Oct 16; 65(2):149-54. PubMed ID: 8911609
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
    Gaffney D, Forster L, Caslake MJ, Bedford D, Stewart JP, Stewart G, Wieringa G, Dominiczak M, Miller JP, Packard CJ.
    Atherosclerosis; 2002 May 16; 162(1):33-43. PubMed ID: 11947895
    [Abstract] [Full Text] [Related]

  • 18. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    Boren J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity TL.
    J Clin Invest; 1998 Mar 01; 101(5):1084-93. PubMed ID: 9486979
    [Abstract] [Full Text] [Related]

  • 19. Occurrence of species of low-density lipoprotein with defective clearance in patients with primary moderate hypercholesterolaemia.
    Vega GL, Grundy SM.
    J Intern Med; 1992 Nov 01; 232(5):405-13. PubMed ID: 1453124
    [Abstract] [Full Text] [Related]

  • 20. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD, Novoselov AV, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biol Chem; 2005 May 01; 386(5):441-52. PubMed ID: 15927888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.